| News

Welcome to the Basel region: Cerdia

30.04.2019

Cerdia’s history starts with Rhodia Acetow more than 100 years ago: The company was founded in 1912 in the Rhone valley in France. Its specialty were polyester and nylon textiles. Later, Rhodia Acetow developed huge business opportunities in producing cigarette filter tow and cellulose acetate. In 2018, the company opened a new chapter in their books: The international headquarters were moved from Freiburg i.B., Germany to Basel. The new stand-alone entity in Basel was rebranded Cerdia in March 2019. Today, Cerdia has an annual turnover of more than 600 million Swiss francs. 1300 employees work for the company with hubs in France, Singapore, the US, Brazil and Russia.

Philippe Rosier, CEO Cerdia (img: Pino Covino)

From tow to timber

The acetate specialists are well-known for their innovative products such as filter tow for IQOS cigarettes, filter tow for super slim cigarettes, coloured or biodegradable tow. While global cigarette consumption is in decline, the application range for acetylation is not: Cerdia promotes a durable timber range under the name Accoya, licensed from the British Accsys Group: Wood acetylation alters the timber, making it more durable and reducing its ability to absorb water by approximately 80 percent. The processed wood is safe from rot, mould and fungi, yet bendable, non-toxic and 100 percent recyclable, making it applicable for façades as well as window frames or outdoor furniture.

Make Cerdia more international

The new positioning reflects the transformation of the company, says Philippe Rosier, CEO of Cerdia: “We chose Basel for our new corporate headquarters to transform the culture of the company from here and make Cerdia more international.” The company set up their management offices in a carefully renovated town house in Basel. Philippe Rosier: “The BaselArea.swiss team did a great job finding this wonderful location and supported us with the administrative part of the transition.” Basel not only offers Cerdia proximity to tobacco companies in Switzerland and a spot within the community of global pharma companies, but also access to the vast network of architectural firms that are settled in the area – optimal for developing the market for Accoya timber.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Bottmedical enters the market with innovative braces
Basel Area Business & Innovation, Innovation, Invest

Bottmedical enters the market with innovative braces

The Basel-based startup Bottmedical has developed clear braces made from bio-based polymers. After closing a successful financing round, the company...

Read More
TargImmune raises nearly 18 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest

TargImmune raises nearly 18 million Swiss francs

The Basel-based biotechnology firm TargImmune has raised 17.7 million Swiss francs as part of a financing round. It now intends...

Read More
KetoSwiss launches first product in the USA
Basel Area Business & Innovation, Innovation, Invest

KetoSwiss launches first product in the USA

The Basel-based biotech startup KetoSwiss develops innovative therapies for neurological disorders. Following a successful capital increase, the company now has...

Read More
For Swiss startups, China might be closer than it seems
Basel Area Business & Innovation, Invest

For Swiss startups, China might be closer than it seems

China wants to strengthen domestic demand and be less dependent on imports. This policy has huge implications for the life...

Read More
Basel Area treads unique path
Basel Area Business & Innovation, Innovation, Invest

Basel Area treads unique path

Basel Area is responsible for both location and innovation promotion. This approach, which is unique across Switzerland, is very successful...

Read More
Alentis secures 67 million US dollars
Basel Area Business & Innovation, Innovation, Invest

Alentis secures 67 million US dollars

The Basel-based biotechnology company Alentis Therapeutics has secured 67 million US dollars in a series B funding round. The funds...

Read More
RocketVax secures partners for coronavirus vaccine in Basel
Basel Area Business & Innovation, Innovation

RocketVax secures partners for coronavirus vaccine in Basel

RocketVax has found cooperation partners for the development of its innovative coronavirus vaccine. The University Hospital of Basel, the University...

Read More
Bright Peak secures investment of 107 million dollars
Basel Area Business & Innovation, Innovation, Invest

Bright Peak secures investment of 107 million dollars

Bright Peak has raised a total of 107 million US dollars as part of a financing round. The biotechnology firm...

Read More
LCB lands major contract
Basel Area Business & Innovation, Innovation, Invest

LCB lands major contract

LCB Sàrl is active in the areas of Human Machine Interface as well as software and electronics development. The company...

Read More
1 2 3 28

Do you have a question? We'd like to hear from you.